CS
NSPR icon

Credit Suisse’s InspireMD NSPR Stock Holding History

Credit Suisse’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed -$66K – 3977
2016
Q4 		$66K Buy
+1
New +$65.7K ﹤0.01% 3995

Other funds holding NSPR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse's NSPR Position: Q1 2017 in Review

Credit Suisse sold out of InspireMD (NSPR) in Q1 2017, closing a stake of 1 share — an estimated $66K sold.

Credit Suisse first reported a position in NSPR in Q4 2016 and held it in 1 quarter. The position peaked at $66K in Q4 2016. 5 funds tracked by Wall St. Rank hold NSPR as of Q1 2017.

  • Credit Suisse reported no remaining InspireMD position as of Q1 2017 after selling out during the quarter.
  • Credit Suisse sold 1 InspireMD share in Q1 2017, an estimated $66K.
  • Credit Suisse first reported a position in InspireMD in Q4 2016 and held it in 1 quarter.
  • Credit Suisse's InspireMD position peaked at $66K in Q4 2016.
  • 5 funds tracked by Wall St. Rank held InspireMD as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.